Ï㽶ÊÓƵ

A Café Scientifique organised by the Research Institute of the MUHC and the Montreal Neurological Institute, supported by the Canadian Institutes of Health research

What happens when our immune systems attack our own bodies? The answer is complex and could be called: type 1 diabetes, multiple sclerosis, psoriasis, or lupus… And these are only a few of the so-called autoimmune diseases. Are they triggered by independent factors, or are they different aspects of the same underlying condition?

Many of the best research teams are now trying to answer these questions. What they learn may profoundly change how we view and treat these pathologies.

Join our panel of top scientists from the Research Institute of the MUHC and the Montreal Neurological Institute to learn about and discuss the latest research findings on autoimmunity.

Dr Constantin Polychronakos - Director of Pediatric Endocrinology at the MUHC

Dr Ciriaco Piccirillo - Director of the laboratory of immuno-regulation in the department of microbiology at the Research Institute of the MUHC

Dr Amit Bar-Or - Director of the Experimental Therapeutics Program, and Scientific Director of the Clinical Research Unit at the Montreal Neurological Institute

Ìý

When? Tuesday April 21st, 2009 at 7:00pm
Where? O Patro Vys - 356, Mont Royal Est

The evening will be hosted by Gerri Barrer, the CBC News health specialist reporter, based in Montreal

Admission is free
Refreshments will be served.


The Research Institute of the Ï㽶ÊÓƵ Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, the university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 600 researchers, nearly 1200 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge.
The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santé du Québec.
For further details visit: .

-30-